Trachoma Serology Points to Ongoing Transmission in Rural Coastal Ecuador
Serologic surveillance in Esmeraldas Province now places trachoma back on the public health agenda for coastal Ecuador. By measuring IgG to Chlamydia trachomatis plasma gene protein 3, investigators found a pattern consistent with ongoing transmission in rural villages and a more mixed signal in the commercial center of Borbón. The signal was strongest in children, the group that best captures recent community exposure and the pace of recent spread.
The result matters because trachoma control depends on identifying communities where infection is still active before irreversible eyelid scarring and blindness accumulate. In settings where clinical grading is difficult to sustain year after year, serology offers a way to estimate transmission intensity from archived or field-collected blood spots. Here, the antibody pattern moved beyond simple prevalence estimates and was translated into the probability that public health action is needed.
Seroconversion Rates Were Higher in Rural Villages Than in Borbón
The analysis drew on 2 studies in Esmeraldas Province. One was the ECoMiD longitudinal birth cohort, which followed children across an urban-rural gradient that included Esmeraldas city, Borbón, and multiple riverine and road-accessible communities. The second was a community-based annual serologic surveillance effort for arbovirus transmission that contributed samples from Borbón and neighboring villages. Together, these sources yielded 2,801 dried blood spots from 1,243 children aged 0–15 years, with testing focused on children 2–15 years of age for the serologic analysis.
The antibody trajectory was not subtle. Pgp3 IgG seroprevalence rose earlier and reached a higher level in rural villages than in Borbón, and the two groups converged only around 13 years of age. Overall seroprevalence in Borbón was 7.0% (95% CI 5.3%–9.0%; 56/799), but the rural communities showed substantial variation, ranging from 0% in Colon de Onzole to 31% in Zancudo.
Among children 1–5 years of age, the seroconversion rate was 4.6 per 100 person-years overall, 1.9 per 100 person-years in Borbón, and 5.7 per 100 person-years in rural villages. In a disease driven by repeated exposure during childhood, those differences are biologically meaningful. Faster seroconversion in young children usually reflects more intense, more sustained transmission in the household and community environment, especially where crowding, water access, and sanitation barriers preserve repeated contact with ocular secretions.
Probability Modeling Moved Rural Communities Into the Action-Needed Range
The study did more than count antibodies. Investigators compared local seroconversion estimates with distributions from 34 global trachoma surveys and used those data to calculate the probability that a community falls into the action-needed or action-not-needed category. For the rural villages, the probability that public health action was needed reached 99.3%. For Borbón, the corresponding probability was 32.0%.
The threshold analysis sharpened the interpretation. A seroconversion rate of 2 per 100 person-years served as a region of high confidence for action not needed, while 4 per 100 person-years marked a region of high confidence for action needed. Rural villages landed squarely in the higher-risk range: the probability of meeting the 4 per 100 person-years threshold was 91.3%. In Borbón, the probability was only 8.8%, while the probability of the lower 2 per 100 person-years threshold was 52.4%.
Those estimates explain why the region cannot be treated as epidemiologically uniform. Borbón sits between urban and rural patterns, and the confidence interval around its seroconversion rate crossed the intermediate range. By contrast, the rural villages clustered in a zone that resembles districts with persistent active transmission seen elsewhere in trachoma-endemic settings.
Why Pgp3 IgG Is a Useful Signal for Elimination Programs
Pgp3 IgG is attractive for surveillance because it reflects prior C. trachomatis exposure and remains informative after mass antimicrobial campaigns. Unlike a single clinical examination, serology can be repeated across years and layered onto existing community surveys. That makes it especially useful where field teams are already collecting dried blood spots for other infectious disease programs.
In trachoma elimination work, the issue is not merely whether infection exists. The practical question is whether transmission is high enough to justify population-level intervention and follow-up. Seroconversion rates answer that question more directly than isolated prevalence snapshots because they measure the flow of new exposure over time rather than a static record of past infection.
The study’s findings are particularly relevant for the Americas, where trachoma control efforts have largely focused on other geographic priorities. Planned surveys in Ecuador have centered on the Amazon basin, yet the data from Esmeraldas suggest the coastal province deserves surveillance attention as well. Rural communities in the Santiago River basin appear to sit within a transmission profile that would justify further investigation and, if confirmed clinically, public health response.
The Main Gaps Are Sampling Design and Clinical Correlation
Two limitations frame how far the findings can be carried. The survey did not use a population-based probability sample with many clusters, the design often recommended for trachoma surveillance. Children 3–5 years of age may therefore be underrepresented, especially in Borbón. The analysis also did not pair serology with clinical trachoma grading or ocular C. trachomatis testing, so antibody positivity cannot be linked directly to present-day eye disease in these children.
Those gaps do not erase the signal, but they do define the next step. Standardized baseline surveys that document active trachoma would provide the clinical anchor needed to judge whether the antibody pattern is tracking current disease or residual exposure from earlier transmission. In a small region where water access, sanitation, and hygiene barriers can sustain spread across household networks, that distinction will shape how aggressively elimination teams should move.
For now, the serologic profile gives Esmeraldas Province a place in the trachoma conversation. Rural villages along the Santiago River basin show a level of antibody acquisition that aligns with communities already considered to need public health action, while Borbón remains in a zone that calls for continued monitoring rather than certainty.